PubMed (OMIM) for id: 5605

Year	Number of Results
1993	2
1998	1
1999	1
2000	2
2001	1
2003	1
2006	2
2007	3
2008	2
2010	1
2011	2
2024	0

1

Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

Nikolaev SI, Rimoldi D, Iseli C, Valsesia A, Robyr D, Gehrig C, Harshman K, Guipponi M, Bukach O, Zoete V, Michielin O, Muehlethaler K, Speiser D, Beckmann JS, Xenarios I, Halazonetis TD, Jongeneel CV, Stevenson BJ, Antonarakis SE. Nikolaev SI, et al. Nat Genet. 2011 Dec 25;44(2):133-9. doi: 10.1038/ng.1026. Nat Genet. 2011. PMID: 22197931

2

Cardiofaciocutaneous syndrome in a mother and two sons with a MEK2 mutation.

Linden HC, Price SM. Linden HC, et al. Clin Dysmorphol. 2011 Apr;20(2):86-88. doi: 10.1097/MCD.0b013e32833ff29d. Clin Dysmorphol. 2011. PMID: 21178588 No abstract available.

3

Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations.

Rauen KA, Tidyman WE, Estep AL, Sampath S, Peltier HM, Bale SJ, Lacassie Y. Rauen KA, et al. Am J Med Genet A. 2010 Apr;152A(4):807-14. doi: 10.1002/ajmg.a.33342. Am J Med Genet A. 2010. PMID: 20358587 Free PMC article.

4

Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.

Schulz AL, Albrecht B, Arici C, van der Burgt I, Buske A, Gillessen-Kaesbach G, Heller R, Horn D, Hübner CA, Korenke GC, König R, Kress W, Krüger G, Meinecke P, Mücke J, Plecko B, Rossier E, Schinzel A, Schulze A, Seemanova E, Seidel H, Spranger S, Tuysuz B, Uhrig S, Wieczorek D, Kutsche K, Zenker M. Schulz AL, et al. Clin Genet. 2008 Jan;73(1):62-70. doi: 10.1111/j.1399-0004.2007.00931.x. Epub 2007 Nov 27. Clin Genet. 2008. PMID: 18042262

5

Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.

Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, Tetsu O. Senawong T, et al. Hum Mol Genet. 2008 Feb 1;17(3):419-30. doi: 10.1093/hmg/ddm319. Epub 2007 Nov 2. Hum Mol Genet. 2008. PMID: 17981815

6

Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.

Scholl FA, Dumesic PA, Barragan DI, Harada K, Bissonauth V, Charron J, Khavari PA. Scholl FA, et al. Dev Cell. 2007 Apr;12(4):615-29. doi: 10.1016/j.devcel.2007.03.009. Dev Cell. 2007. PMID: 17419998 Free article.

7

Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.

Mittal R, Peak-Chew SY, McMahon HT. Mittal R, et al. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18574-9. doi: 10.1073/pnas.0608995103. Epub 2006 Nov 20. Proc Natl Acad Sci U S A. 2006. PMID: 17116858 Free PMC article.

8

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.

Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. Rodriguez-Viciana P, et al. Science. 2006 Mar 3;311(5765):1287-90. doi: 10.1126/science.1124642. Epub 2006 Jan 26. Science. 2006. PMID: 16439621

9

Mek2 is dispensable for mouse growth and development.

Bélanger LF, Roy S, Tremblay M, Brott B, Steff AM, Mourad W, Hugo P, Erikson R, Charron J. Bélanger LF, et al. Mol Cell Biol. 2003 Jul;23(14):4778-87. doi: 10.1128/MCB.23.14.4778-4787.2003. Mol Cell Biol. 2003. PMID: 12832465 Free PMC article.

10

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.

Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. Pleschka S, et al. Nat Cell Biol. 2001 Mar;3(3):301-5. doi: 10.1038/35060098. Nat Cell Biol. 2001. PMID: 11231581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year